Resistance to Dihydroartemisinin

This publication has 10 references indexed in Scilit:

• Low efficacy of the combination artesunate plus amodiaquine for uncomplicated falciparum malaria among children under 5 years in Kailahun, Sierra Leone
  Tropical Medicine & International Health, 2006
• Prevalence of In Vitro Resistance to Eleven Standard or New Antimalarial Drugs among Plasmodium falciparum Isolates from Pointe-Noire, Republic of the Congo
  Journal of Clinical Microbiology, 2006
• Resistance of Plasmodium falciparum field isolates to in-vitro artemether and point mutations of the SERCA-type PfATPase6
  The Lancet, 2005
• Artemisinin-based combination therapies (ACTs): Best hope for malaria treatment but inaccessible to the needy!
  Acta Tropica, 2005
• A single amino acid residue can determine the sensitivity of SERCAs to artemisinins
  Nature Structural & Molecular Biology, 2005
• Are Transporter Genes Other than the Chloroquine Resistance Locus ( pfcrt ) and Multidrug Resistance Gene ( pfmdr ) Associated with Antimalarial Drug Resistance?
  Antimicrobial Agents and Chemotherapy, 2005
• WHO, the Global Fund, and medical malpractice in malaria treatment
  The Lancet, 2004
• RECRUDESCENCE IN ARTESUNATE-TREATED PATIENTS WITH FALCIPARUM MALARIA IS DEPENDENT ON PARASITE BURDEN NOT ON PARASITE FACTORS
  The American Journal of Tropical Medicine and Hygiene, 2003
• In vitro activity of dihydroartemisinin against clinical isolates of Plasmodium falciparum in Yaounde, Cameroon.
  The American Journal of Tropical Medicine and Hygiene, 1999
• [Plasmodium falciparum: interpretation of the semi-microtest of in vitro chemosensitivity by H3-hypoxanthine incorporation].
  1984